Alcohol use in patients with chronic liver disease

Daniel Fuster, Jeffrey H. Samet

    Producció científica: Contribució a revistaArticle de revisióRecercaAvaluat per experts

    147 Cites (Scopus)

    Resum

    Copyright © 2018 Massachusetts Medical Society. Globally, alcohol consumption is the seventh leading risk factor for both death and the burden of disease and injury.1 Alcohol use accounts for 6.8% of age-standardized deaths in men and 2.2% in women, with a disproportionate effect on young people.1 The overall costs associated with alcohol use represent more than 1% of the gross national product in high-and middle-income countries, with the costs of social harm (e.g., violence and road accidents) being far greater than health costs alone.2 In short, except for tobacco, alcohol accounts for a higher burden of disease than any other drug.3 In this review, we discuss the effects of alcohol use on various forms of liver disease, as well as the assessment and treatment of alcohol use in patients with chronic liver disease.
    Idioma originalAnglès
    Pàgines (de-a)1251-1261
    RevistaNew England Journal of Medicine
    Volum379
    Número13
    DOIs
    Estat de la publicacióPublicada - 27 de set. 2018

    Fingerprint

    Navegar pels temes de recerca de 'Alcohol use in patients with chronic liver disease'. Junts formen un fingerprint únic.

    Com citar-ho